Braidwell LP

SEC CIK: 0001920938
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

NKTR holding history

Nektar Therapeutics in every 13F filed by Braidwell LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NKTR overview All 13F holders of NKTR Full Q2 2026 holdings

Shares (Q2 2026): 473,617
Value: $33.1M
% of portfolio: 1.2%
Quarters held: 3; Since Q4 2022

Holdings of NKTR by Braidwell LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	473,617	$33.1M	1.2%	+250,916+112.7%	Added	Holders
Q1 2026	222,701	$16.0M	0.5%	+222,701	New	Holders
Q1 2023	0	$0	0.0%	−620,280−100.0%	Sold out	Holders
Q4 2022	620,280	$1.40M	<0.1%	–	No prior filing	Holders